期刊文献+

黄连素抑制肺腺癌核转录因子-κB活性的影响及其与顺铂耐药关系研究 被引量:1

Effect of berberine on the reversing cisplatin-resistant of lung adenocarcinoma cell by inhibiting nuclear factor-κB activity
下载PDF
导出
摘要 目的:观察黄连素对肺癌细胞中顺铂细胞毒性的影响并探讨其机制。方法:选用肺癌顺铂(CDDP)耐药细胞株A549/CDDP,四甲基偶氮唑蓝法测定药物对细胞存活率的影响,蛋白免疫印记法测定IκBα、p65的表达水平。并用p65 siRNA转染A549/CDDP细胞沉默p65的表达,而降低核转录因子(NF)-κB的活性。结果:CDDP耐药肺癌细胞A549/CDDP与敏感细胞A549相比,p65的表达水平显著升高,而IκBα的表达水平显著降低,p65 siRNA沉默A549/CDDP细胞p65的表达降低NF-κB的活性后能显著逆转CDDP耐药(P〈0.01);20μmol/L的黄连素能显著增加A549/CDDP细胞对CDDP的敏感性,且5~20μmol/L的黄连素能浓度依赖性地降低A549/CDDP细胞中p65的表达,但增加IκBα的表达(P〈0.01)。结论:黄连素通过抑制NF-κB的活性逆转肺腺癌细胞中CDDP耐药。 Objective: To observe the effects of berberine on the toxicity of CDDP,and its mechanism. Methods: The cell survival rate,and expressions of IκBα and p65 in CDDP-resistant A549 cell line( A549 / CDDP) were measured by MTT assay and westen blotting,respectively. The expression of p65 was silenced by p65 siRNA transfecting the A549 / CDDP cells,which was used to decrease the NF-κB activity. Results: Compared with the CDDP sensitive cells( A549 cells),the expressions of p65 and IκBα increased and decreased significantly in A549 / CDDP cells,respectively( P〈0. 01). The activity of NF-κB was decreased by the p65 siRNA silencing the expression of p65 in A549 / CDDP cells,which could reversed the CDDP resistance( P〈0. 01). The 20 μmol / L berberine could obviously enhance the sensitivity of A549 / CDDP cells to CDDP,and 5 to 20 μmol / L berberine could decreased the expression of p65 in a dose-dependent manner,while the expression of IκBα was obviously enhanced by berberine( P〈0. 01). Conclusions: Berberine can reverse the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting NF-κB.
出处 《蚌埠医学院学报》 CAS 2015年第12期1624-1627,共4页 Journal of Bengbu Medical College
基金 安徽省自然科学基金青年基金项目(1508085QH151)
关键词 肺肿瘤 黄连素 CDDP 核转录因子-ΚB 耐药 berberine cisplatin nuclear factor-κB lung adenocarcinoma drug resistance
  • 相关文献

参考文献15

  • 1Baldwin AS Jr.Series introduction:the transcription factor NF-κB and human disease[J].J Clin Investig,2001,107(1):3-6.
  • 2Wang CY,Mayo MW,Korneluk RG,et al.NF-κB antiapoptosis:induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation[J].Science,1998,281(5383):1680-1683.
  • 3Xu Y,Villalona-Calero MA.Irinotecan:mechanism of tumor resistance and novel strategies for modulating its activity[J].Ann Oncol,2002,13(12):1841-1851.
  • 4Yang L,Zhou Y,Li Y,et al.Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells[J].Cancer Lett,2015,357(2):520-526.
  • 5Fang XJ,Jiang H,Zhu YQ,et al.Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells[J].Oncol Rep,2014,31(6):2735-2742.
  • 6Sui H,Pan SF,Feng Y,et al.Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway[J].BMC Complement Altern Med,2014,14:279.
  • 7Heavey S,Godwin P,Baird AM,et al.Strategic targeting of the PI3K-NF-κB axis in cisplatin-resistant NSCLC[J].Cancer Biol Ther,2014,15(10):1367-1377.
  • 8Sai K,Li WY,Chen YS,et al.Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells[J].Am J Chin Med,2014,42(2):485-503.
  • 9Yu M,Tong X,Qi B,et al.Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF-κB[J].Mol Med Rep,2014,9(1):249-254.
  • 10Li F,Sethi G.Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy[J].Biochim Biophys Acta,2010,1805(2):167-180.

同被引文献13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部